Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attenuating Ischemia and Reperfusion Injury Using NAD<sup>+</sup>-Loaded Nanoparticles in Mouse Kidneys.

Transplantation direct·2026
Same author

Nanoparticle-Based Antigen Delivery: Advancing Immunization Strategies against Infectious Pathogens.

Biomaterials research·2026
Same author

Synonymous editing alters ion channel function, favoring prime editing for retinal disease correction.

International journal of biological sciences·2026
Same author

Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo.

Advanced healthcare materials·2026
Same author

Triphenylphosphonium-functionalised cubosomes for mitochondrial-targeted delivery of 5-fluorouracil and lycopene in skin cancer therapy.

Journal of drug targeting·2026
Same author

Identification of flavonoids in the endemic taxa <i>Haplanthodes verticillata</i>, <i>Haplanthodes plumosa</i>, <i>Haplanthodes tentaculata</i>, <i>Haplanthodes neilgherryensis</i> and <i>Haplanthodes neilgherryensis</i> var. <i>toranganensis</i> by liquid chromatography quadrupole time of flight mass spectrometry.

Natural product research·2025

Related Experiment Video

Updated: May 14, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Lectin functionalized nanocarriers for gene delivery.

Virendra Gajbhiye1, Shaoqin Gong

  • 1Department of Biomedical Engineering and Wisconsin Institutes for Discovery, University of Wisconsin-Madison, WI 53715, USA.

Biotechnology Advances
|January 26, 2013
PubMed
Summary
This summary is machine-generated.

Targeting genetic material using lectins or carbohydrates enhances gene therapy. This review explores nanovectors with these targeting ligands for improved gene delivery and transfection efficiency.

More Related Videos

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

Related Experiment Videos

Last Updated: May 14, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Drug Delivery Systems

Background:

  • Gene therapy offers promising disease treatment but faces challenges with transfection efficiency.
  • Non-viral gene delivery vectors are preferred over viral vectors due to safety concerns.
  • Targeted delivery enhances therapeutic efficacy by directing genetic material to specific sites.

Purpose of the Study:

  • To review gene delivery nanovectors conjugated with carbohydrates or lectins.
  • To highlight the role of carbohydrates and lectins in enhancing gene transfection.
  • To discuss direct and reverse lectin targeting strategies for improved gene delivery.

Main Methods:

  • Review of recent literature on non-viral gene delivery systems.
  • Analysis of nanovectors utilizing carbohydrates and lectins as targeting moieties.
  • Investigation of receptor-mediated endocytosis pathways in targeted gene delivery.

Main Results:

  • Carbohydrate and lectin conjugation significantly improves gene transfection efficiency.
  • Targeting ligands facilitate enhanced cellular uptake via receptor-mediated endocytosis.
  • Specific lectin-carbohydrate interactions enable precise targeting of genetic material.

Conclusions:

  • Carbohydrate- and lectin-conjugated nanovectors represent a promising strategy for efficient gene therapy.
  • Targeted gene delivery using lectins/carbohydrates overcomes limitations of non-targeted approaches.
  • Further development of these targeted nanovectors is crucial for clinical translation.